These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6734922)
21. [Buflomedil chlorhydrate in peripheral vasculopathies]. Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055 [No Abstract] [Full Text] [Related]
22. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy]. Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748 [No Abstract] [Full Text] [Related]
24. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease]. Lemke R; Klaus D Vasa; 1984; 13(2):171-4. PubMed ID: 6741240 [No Abstract] [Full Text] [Related]
25. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination]. Marci M; Albiani B; Ricci M; Russo F Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083 [TBL] [Abstract][Full Text] [Related]
26. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies]. Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209 [No Abstract] [Full Text] [Related]
27. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs]. Warembourg G; Carre A; Ginestet A; Lambert M Lille Med; 1976 Dec; 21 Suppl 4():898-901. PubMed ID: 1018614 [No Abstract] [Full Text] [Related]
29. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution]. Visconti W; Grillo N Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842 [TBL] [Abstract][Full Text] [Related]
30. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil]. Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940 [TBL] [Abstract][Full Text] [Related]
31. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)]. Schafé MK Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042 [No Abstract] [Full Text] [Related]
32. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs. Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164 [TBL] [Abstract][Full Text] [Related]
33. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs]. Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756 [TBL] [Abstract][Full Text] [Related]
34. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy]. Paoletti V; Mammarella A; Alessandrini A; Barlattani M Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843 [No Abstract] [Full Text] [Related]
35. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study]. Minerva Med; 1985 Oct; 76(39):1803-11. PubMed ID: 4047463 [TBL] [Abstract][Full Text] [Related]
36. Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease. Perego MA; Sergio G; Espureo M; Francisci A; Artale F Curr Med Res Opin; 1982; 8(3):178-87. PubMed ID: 7128189 [TBL] [Abstract][Full Text] [Related]
37. [The effect of lysine acetylsalicylate on hemorrheological changes induced through ischemic exertion in patients with vascular disease]. Vittoria A; Guerrini M; Pieragalli D; Del Bigo C; Martelli G; Franchi M; Messa G; Blardi P; Galigani C; Di Perri T Ric Clin Lab; 1983; 13 Suppl 3():315-21. PubMed ID: 6231713 [TBL] [Abstract][Full Text] [Related]
38. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. ; Leizorovicz A; Becker F Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283 [TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study]. Sunder-Plassmann L; Gandolfo AM; Utz C MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678 [No Abstract] [Full Text] [Related]
40. [Effects of buflomedil on peripheral arteriopathies. An open clinical study]. Longo FN; Potortì F; Urbano O; Perroni GB Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]